
Deborah Hall
The Parkinson’s Foundation Chair of Neurological Sciences · Rush University Medical Center
Credentials: · · · · · ·
History
PresentNeurological Sciences Department · Rush University Medical Center
PresentSection of Movement Disorders · Rush University Medical Center
PresentDepartment of Neurological Sciences · Rush University Medical Center
Research
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population
JAMA · 2004 · 503 citations
JAMA Neurology · 2018 · 411 citations
Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines
Review · Movement Disorders · 2007 · 250 citations

40 papers
- ML
26 papers

25 papers

18 papers

14 papers

12 papers

12 papers
- GP
11 papers
Grants
- 2025–2030
Clinical Outcome Assessment and Treatment Monitoring Markers for Clinical Trial Readiness in FXTAS
National Institute of Neurological Disorders and Stroke · U01
PI · $2.3M · University of California at Davis
- 2022–2027
Racial Disparities in Parkinson Disease- Clinical Phenotype, Management and Genetics
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $3.2M · Rush University Medical Center
- 2013–2018
Adult Neurological Phenotypes of Fragile X Gray Zone Expansion
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.2M · Rush University Medical Center
- 2006–2012
Prevalence of FMRI Expansions in Movement Disorders
National Institute of Neurological Disorders and Stroke · K23
Contact PI · $881.3K · Rush University Medical Center
Clinical trials
- 2020–2022
Prebiotics in the Parkinson's Disease Microbiome
Principal investigator · Completed
Rush University Medical Center
- 2015–2017
Citocoline for Treatment in Fragile X-associated Tremor/Ataxia Syndrome
Principal investigator · Completed · Phase 2
Rush University Medical Center
- 2010–2018
Varenicline for Gait and Balance Impairment in Parkinson Disease
Principal investigator · Completed · Phase 2
Rush University Medical Center
- 2026–2030
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals



